Prospective evaluation of finger two-point discrimination and carpal tunnel syndrome among women with breast cancer receiving adjuvant aromatase inhibitor therapy.

Jennifer Y ShengAmanda L BlackfordAditya BardiaRaghunandan VenkatGedge RossonJon GilesDaniel F HayesStacie C JeterZhe ZhangJill HaydenAnne NguyenAnna Maria StornioloKarineh TarpinianNorah Lynn HenryVered Stearns

Published in: Breast cancer research and treatment (2019)

For women receiving adjuvant AI, 2-PD scores were significantly worse at 3 months compared to baseline. Studies are required to assess whether change in 2-PD is an adequate objective assessment for CTS with AI therapy. Early diagnosis of CTS may expedite management, improve AI adherence, and enhance breast cancer outcomes.

Keyphrases

artificial intelligence
early stage
polycystic ovary syndrome
machine learning
deep learning
breast cancer risk
stem cells
pregnancy outcomes
glycemic control
case control
metabolic syndrome
skeletal muscle
mesenchymal stem cells
insulin resistance